Related Experiment Videos
At how many histocompatibility loci do congenic mouse strains differ? Probability estimates and some implications.
The Journal of Heredity
|January 1, 1981
Summary
Congenic strains may share multiple linked histocompatibility genes more often than expected. This finding impacts interpreting results from immunological studies using these strains.
Area of Science:
- Immunogenetics
- Molecular Biology
- Histocompatibility
Background:
- Congenic strains are crucial inbred animal models for studying immune responses.
- Histocompatibility (H) genes determine tissue compatibility and are key in transplantation and immune research.
- Understanding genetic differences between congenic strains and their partners is vital for experimental validity.
Purpose of the Study:
- To derive a mathematical expression for the probability of multiple linked histocompatibility gene differences between congenic strains and their inbred partners.
- To assess the likelihood of such genetic discrepancies under typical experimental conditions.
- To discuss the implications of unsuspected genetic differences for interpreting immunological data.
Main Methods:
- Mathematical derivation of probability expression.
- Analysis of typical variable values in congenic strain production.
- Discussion of immunological concepts: antigenic strength, H-locus polymorphism, H antigen tissue distribution, and cell-mediated lympholysis (CML) assays.
Main Results:
- The probability of congenic strains differing by multiple linked histocompatibility genes is often substantial.
- This probability is influenced by the initial number of incompatibilities and the number of backcross generations.
- Unsuspected multiple incompatibilities can complicate data interpretation in immunological experiments.
Conclusions:
- Researchers must consider the high probability of multiple linked H-gene differences when using congenic strains.
- Experimental designs and data interpretation should account for potential unsuspected genetic disparities.
- Further investigation into the impact of these genetic differences on specific assays like CML is warranted.